Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies

Using mendelian randomization, Roman Pfister and colleagues demonstrate a potentially causal link between low levels of B-type natriuretic peptide (BNP), a hormone released by damaged hearts, and the development of type 2 diabetes.

[1]  Mark I. McCarthy,et al.  Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance , 2011, Diabetes.

[2]  H. Bøtker,et al.  Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. , 2010, International journal of cardiology.

[3]  E. Montanya,et al.  The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function. , 2010, Endocrinology.

[4]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[5]  S. Frenda,et al.  Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes. , 2010, The American journal of cardiology.

[6]  V. Salomaa,et al.  Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes , 2010, PloS one.

[7]  J. Gustafsson,et al.  Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. , 2009, Molecular endocrinology.

[8]  R. Ritchie,et al.  B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target. , 2009, Current molecular medicine.

[9]  K. Nakao,et al.  Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity , 2009, Diabetes.

[10]  K. Stefánsson,et al.  The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. , 2009, Human molecular genetics.

[11]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[12]  D. Levy,et al.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure , 2009, Nature Genetics.

[13]  L. R. Potter,et al.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. , 2009, Handbook of experimental pharmacology.

[14]  J. Korinek,et al.  Nesiritide in acute decompensated heart failure: current status and future perspectives. , 2008, Reviews in cardiovascular medicine.

[15]  N. Wareham,et al.  Occupational social class, educational level, smoking and body mass index, and cause-specific mortality in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort , 2008, European Journal of Epidemiology.

[16]  M. Emi,et al.  Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. , 2007, Biochemical and biophysical research communications.

[17]  N. Sheehan,et al.  Mendelian randomization as an instrumental variable approach to causal inference , 2007, Statistical methods in medical research.

[18]  D. Lawlor,et al.  Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. , 2007, Annals of epidemiology.

[19]  Inês Barroso,et al.  TCF7L2 Polymorphisms Modulate Proinsulin Levels and β-Cell Function in a British Europid Population , 2007, Diabetes.

[20]  M. McCarthy,et al.  Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. , 2007, Human molecular genetics.

[21]  Diederick E Grobbee,et al.  Analysis of case-cohort data: a comparison of different methods. , 2007, Journal of clinical epidemiology.

[22]  D. Levy,et al.  Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals , 2007, Circulation.

[23]  M. Rich,et al.  Genetic Variation in the B-Type Natiuretic Peptide Pathway Affects BNP Levels , 2007, Cardiovascular Drugs and Therapy.

[24]  S. Gottlieb,et al.  B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. , 2006, American heart journal.

[25]  Juan P Casas,et al.  Estimation of bias in nongenetic observational studies using "mendelian triangulation". , 2006, Annals of epidemiology.

[26]  Y. Pinto,et al.  Is brain natriuretic peptide production decreased in obese subjects? , 2006, Journal of the American College of Cardiology.

[27]  N. Day,et al.  Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.

[28]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[29]  N. Wareham,et al.  Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study. , 2003, Human molecular genetics.

[30]  Daniel Levy,et al.  The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening , 2003, Annals of Internal Medicine.

[31]  Wen-Sheng Huang,et al.  Circulating brain natriuretic peptide values in healthy men before and after exercise. , 2002, Metabolism: clinical and experimental.

[32]  M. Berlan,et al.  Natriuretic peptides: a new lipolytic pathway in human adipocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  N. Day,et al.  Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. , 2000, Diabetes care.

[34]  T Lauritzen,et al.  The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening , 2000, International Journal of Obesity.

[35]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[36]  References , 1971 .